Navigation Links
Help for California Fire Evacuees Possible Through Partnership for Prescription Assistance
Date:10/23/2007

WASHINGTON, Oct. 23 /PRNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement regarding the California wildfires:

"Californians who have been affected by the recent wildfires -- and who are uninsured or underinsured -- should know that help getting the medicines they need may be available through the Partnership for Prescription Assistance. The PPA, sponsored by America's pharmaceutical research companies, is dedicated to helping Americans who lack adequate health care coverage. Now, as residents of southern California face the destruction being caused by these wildfires, the PPA is offering to help qualified patients get assistance even faster.

"Struggling Californians who are having trouble getting the medicines they need may find expedited help through PPA's disaster relief program by calling the PPA's toll-free number, 1-888-4-PPA-NOW (1-888-477-2669), or user-friendly Web site, available at http://www.pparx.org.

"Since April 2005, the PPA has helped more than 4.3 million uninsured or underinsured Americans -- including 250,000 in California -- find programs that provide prescription medicines for free or nearly free. It helps patients in need obtain access to more than 475 public and private patient assistance programs, including 180 programs offered by pharmaceutical companies. The PPA can also help Californians find out about programs offered by the state, such as Medi-Cal, Healthy Families and Access for Infants and Mothers.

"In addition, the PPA provides information on nearly 10,000 free healthcare clinics and has connected more than 163,340 patients with clinics and healthcare providers in their communities.

"Through the PPA, America's pharmaceutical research companies are continuing to make tremendous inroads by assisting struggling Americans who need it most, and this is especially true during California's time of need."

More than 1,300 national and local organizations, including the American Academy of Family Physicians, American Cancer Society, Easter Seals, National Urban League and the National Association of Chain Drug Stores, are working with America's pharmaceutical research companies to help spread the word about the PPA.

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $43 billion in 2006 in discovering and developing new medicines. Industry-wide research and investment reached a record $55.2 billion in 2006.

PhRMA Internet Address: http://www.phrma.org

For information on how innovative medicines save lives, visit:

http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit:

http://www.pparx.org

For information on the danger of imported drugs, visit:

http://www.buysafedrugs.info


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Passive smoking declared as Toxic in California
2. California Employers may need to Fork out more on Health Benefits
3. An urgent need for prison reforms: California!
4. Death by Smog in California
5. PE Minimums Violations:California Schools Blamed
6. California: Go Ahead For Drug Discount Initiative
7. Students Fail In Fitness Test In California
8. Southern California Wildfires Pose Health Risks to Children
9. About One Third of Children Overweight in California
10. Californian Baby Creates History - Born from a Frozen Egg and Sperm
11. Hunt for Sea Delicacy Taking a Toll in California
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ... Care Association™ (ALCA) to conduct a survey that takes a closer look at cases ... illustrates the prevalence and causes of TBI among the aging population, and identifies the ...
(Date:2/10/2016)... ... 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company ... and full year ended December 31, 2015 on Monday, February 29, 2016 after the ... investment community following the release at 4:30 PM ET. Investors interested in participating by ...
(Date:2/10/2016)... ... 2016 , ... For additional information contact Phyllis Strupp 480-488-5858 , Brain improves ... The Ultimate Guide to Brain Training" by award-winning author Phyllis Strupp explains ... is March 16, 2016. A free review copy is available to the media ...
(Date:2/10/2016)... ... February 10, 2016 , ... IDEX Health & Science, LLC ... steel (PLS) columns combine the strength of traditional stainless steel with the chemical ... samples while operating at ultra-high pressures of 20,000 psi. The higher operating pressures ...
(Date:2/10/2016)... , ... February 10, 2016 , ... The recreational use ... enthusiasts in the state still face a lot of restrictions as to where they ... intended for private, personal use” and that cannabis “may not be consumed openly or ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... SAN DIEGO , Feb. 10, 2016 ... viral gene therapy manufacturing, and Renova™ Therapeutics, a biopharmaceutical ... and other chronic diseases, have entered into a Manufacturing ... produce cGMP-grade RT-100 (Ad5.hAC6) Drug Product for use in ... --> This relationship will leverage Lonza,s ...
(Date:2/10/2016)... Calif. , Feb. 10, 2016  Rich Pharmaceuticals, ... today announced a 1-for-100 reverse split of its issued ... opening of trading on Thursday, February 11, 2016. The ... under new CUSIP number 76303T308 and temporary ticker symbol ... commence trading under the ticker symbol (RCHA).  ...
(Date:2/10/2016)... , Feb. 10, 2016  The ALS Association, in partnership ... Grand Challenge to generate a biomarker to track TDP43 aggregation. ... up to a $1 million investment. ... disease that affects nerve cells in the brain and the ... initiate and control muscle movement, which often leads to total ...
Breaking Medicine Technology: